225 related articles for article (PubMed ID: 18755702)
1. The immunodeficiency of chronic lymphocytic leukaemia.
Hamblin AD; Hamblin TJ
Br Med Bull; 2008; 87():49-62. PubMed ID: 18755702
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin in chronic lymphocytic leukaemia.
Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
[TBL] [Abstract][Full Text] [Related]
3. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
Le Dieu R; Gribben J
Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
[TBL] [Abstract][Full Text] [Related]
4. Infection and immunity in chronic lymphocytic leukemia.
Tsiodras S; Samonis G; Keating MJ; Kontoyiannis DP
Mayo Clin Proc; 2000 Oct; 75(10):1039-54. PubMed ID: 11040852
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
6. Impairments in immune cell function in B cell chronic lymphocytic leukemia.
Bartik MM; Welker D; Kay NE
Semin Oncol; 1998 Feb; 25(1):27-33. PubMed ID: 9482524
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin replacement in chronic lymphocytic leukaemia.
Bunch C
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):419-22. PubMed ID: 3065737
[TBL] [Abstract][Full Text] [Related]
9. Secondary immunodeficiency in lymphoproliferative malignancies.
Friman V; Winqvist O; Blimark C; Langerbeins P; Chapel H; Dhalla F
Hematol Oncol; 2016 Sep; 34(3):121-32. PubMed ID: 27402426
[TBL] [Abstract][Full Text] [Related]
10. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
11. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.
Morrison VA
Best Pract Res Clin Haematol; 2010 Mar; 23(1):145-53. PubMed ID: 20620978
[TBL] [Abstract][Full Text] [Related]
12. Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia.
Hersey P; Wotherspoon J; Reid G; Gunz FW
Clin Exp Immunol; 1980 Mar; 39(3):698-707. PubMed ID: 6445798
[TBL] [Abstract][Full Text] [Related]
13. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
14. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
[TBL] [Abstract][Full Text] [Related]
15. Definition of a target for immunotherapy and results of the first Peptide vaccination study in chronic lymphocytic leukemia.
Tabarkiewicz J; Giannopoulos K
Transplant Proc; 2010 Oct; 42(8):3293-6. PubMed ID: 20970674
[TBL] [Abstract][Full Text] [Related]
16. [Immunoglobulins--merely expensive or also useful?].
Paar WD
Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages.
Hus I; Kawiak J; Tabarkiewicz J; Radej S; Hoser G; Bojarska-Junak A; Schmitt M; Giannopoulos K; Dmoszynska A; Rolinski J
Oncol Rep; 2008 Aug; 20(2):443-51. PubMed ID: 18636210
[TBL] [Abstract][Full Text] [Related]
19. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]